In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant Klebsiella pneumoniae with Different Resistance Mechanisms in China-Reference-Cited by-同舟云学术

In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant Klebsiella pneumoniae with Different Resistance Mechanisms in China

Published:2021-03 Issue: Volume:Volume 14 Page:917-928
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Liu Enbo,Jia Peiyao,Li Xue,Zhou Menglan^ORCID,Kudinha Timothy^ORCID,Wu Chuncai,Xu Yingchun,Yang Qiwen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference47 articles.

1. Centres for Disease Control and Prevention (US). Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention; 2013.

2. Global Spread of Carbapenemase-producingEnterobacteriaceae

3. Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China

4. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

5. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides against VIM-producing Enterobacteriaceae;Microbiology Spectrum;2024-08-20

2. In Vitro Synergistic Effect of Colistin with Fosfomycin Against Carbapenem-Resistant Klebsiella pneumoniae;Cureus;2024-08-06

3. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae;Microbiology Spectrum;2024-06-04

4. Mechanisms of Antibiotic Resistance and Developments in Therapeutic Strategies to Combat Klebsiella pneumoniae Infection;Infection and Drug Resistance;2024-03

5. In Vitro Activity of Amikacin Combined with Meropenem, Colistin and Ceftazidime/Avibactam Against Genetically Distinct Multidrug-Resistant K. Pneumoniae, a. Baumannii and S. Marcescens Isolates Using Three Methods;2024